Lv4
432 积分 2022-07-22 加入
Disruption of RBPJ in liver cancer-infiltrating T cells enhances antitumor immunity through remodeling epigenetic landscape
2个月前
已完结
Epigenetic regulation of the DNMT1/MT1G/KLF4/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma
3个月前
已完结
Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-κB pathway activation
5个月前
已关闭
RBM15/IGF2BP3 promotes immune escape in bladder cancer by enhancing m6A modification of PFKFB4
9个月前
已完结
Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial
1年前
已完结
Características inmunológicas claves en la fisiopatología de la sepsis. Infectio
1年前
已完结
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration
1年前
已完结
RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma
1年前
已完结
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
1年前
已完结
Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability
1年前
已完结
皖公网安备34019202002308
